HPV is not one virus, and different HPV types behave differently. This article explains low-risk and high-risk types, why exposure is usually invisible, which symptoms deserve review, and why HPV testing is mainly part of cervical screening rather than a general body-wide test.

HPV is not one virus, and different HPV types behave differently. This article explains low-risk and high-risk types, why exposure is usually invisible, which symptoms deserve review, and why HPV testing is mainly part of cervical screening rather than a general body-wide test.

Why HPV type matters

One of the most confusing parts of HPV is that the same short name covers many different viruses. Some types are mostly linked with warts. Some types are linked with cancer. Some infections disappear so quietly that a person never knows they happened. This is why a useful HPV conversation needs more detail than simply saying, "HPV is common." It is common, but the type, the place in the body, and whether the infection persists all matter.

For sexually transmitted HPV, doctors usually speak about low-risk and high-risk types. Low-risk types are also called non-oncogenic, meaning they are not the types that usually cause cancer. High-risk types are called oncogenic because long-lasting infection can cause cell changes that may develop into cancer over time.

The National Cancer Institute lists 12 high-risk types: HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, and 59. Of these, HPV 16 and HPV 18 are responsible for most HPV-related cancers. The current 9-valent vaccine targets seven high-risk types linked to most HPV-related cancers: 16, 18, 31, 33, 45, 52, and 58. It also targets HPV 6 and 11, the low-risk types that cause most genital warts.

Types that usually do not cause cancer

Low-risk HPV types can still matter because they can cause visible and distressing disease. Genital warts may appear as small bumps, flat lesions, or grouped growths around the genital or anal area. They may itch, feel uncomfortable, bleed if irritated, or cause no symptoms at all. CDC guidance says diagnosis is usually made by visual inspection. HPV testing is not recommended for diagnosing genital warts because the test does not confirm the diagnosis and does not guide wart treatment.

HPV 6 and HPV 11 cause most genital warts. They can also be linked with recurrent respiratory papillomatosis, a rare condition in which wart-like growths develop in the upper airway. This is uncommon, but it shows why "low-risk" does not mean "irrelevant." It means the cancer risk is low compared with high-risk HPV types.

Treatment for warts is available. Some treatments are applied by the patient and others are performed by a healthcare provider. If warts are left untreated, they may go away, stay the same, or grow in size or number. Treatment can remove visible warts, but it does not cure the virus itself, and warts can sometimes recur, especially in the first months after treatment.

Types that can produce cancer

High-risk HPV does not usually announce itself. A person cannot feel a high-risk HPV infection starting. There may be no pain, no discharge, no fever, no wart, and no visible sign. This is why cervical screening is so important where it is recommended: it can find high-risk HPV or HPV-related cell changes before cancer develops.

Persistent high-risk HPV can cause cell changes in the cervix, anus, oropharynx, penis, vagina, and vulva. These changes do not happen overnight. Most infections clear. When they do not clear, cancer usually takes years to develop. The difficult part is that a person may feel well during that long period.

Different cancers have different symptom patterns. Cervical precancer often causes no symptoms. Anal cancer may cause bleeding, pain, itching, or a lump near the anus, but these symptoms can also come from non-cancer causes. Oropharyngeal cancer may cause a long-lasting sore throat, ear pain, hoarseness, swollen lymph nodes, pain when swallowing, or unexplained weight loss. Penile cancer can cause sores, discharge, bleeding, redness, irritation, or a lump. Vulvar cancer may cause itching, bleeding, or a lump or sore on the vulva. Vaginal cancer may cause pain or abnormal vaginal bleeding. None of these symptoms proves cancer, but persistent or unusual symptoms deserve medical review.

Can you recognise exposure?

Usually, no. HPV exposure is often invisible. A partner can transmit HPV without knowing they have it. A person can acquire HPV and clear it without ever noticing. A positive HPV test or wart diagnosis does not usually tell you when exposure happened.

This matters because people often try to create a timeline. They may connect the diagnosis to a recent partner, a new relationship, or a difficult moment in the relationship. Sometimes the timing may be recent, but often it cannot be known. HPV can become medically visible months or years after exposure. CDC guidance specifically notes that partners tend to share HPV and that having HPV does not mean either partner had sex outside the relationship.

There are some things you can notice. You can notice visible warts. You can notice bleeding, pain, lumps, sores, or symptoms that last longer than expected. You can notice whether you are up to date with cervical screening if you have a cervix. But you usually cannot notice the original exposure itself.

What HPV tests can and cannot show

HPV testing is not a general body-wide test. It is mainly used in cervical cancer screening and follow-up. Depending on age, country, and local guidance, cervical screening may use a Pap test, a high-risk HPV test, or both. The goal is not to find every past exposure. The goal is to identify people at higher risk of cervical precancer so they can be followed and treated if needed.

For the general public, there are no standard screening tests for HPV-related cancers of the oropharynx, penis, vagina, or vulva. There is also no standard anal cancer screening test for the general public, although some higher-risk groups may be assessed by specialists. The National Cancer Institute states that cervical cancer is currently the only HPV-caused cancer with FDA-approved screening tests.

This can feel frustrating, especially for men who ask for a simple HPV test and are told that one is not available for them. The honest answer is that medicine can test some things well and cannot yet test everything well. That is why prevention, vaccination, awareness of persistent symptoms, and appropriate specialist review matter.

How to use this information without panic

Knowing that HPV can be silent should not lead to fear of every symptom. Most genital irritation, throat pain, mouth ulcers, anal discomfort, and abnormal bleeding have causes other than cancer. The practical rule is persistence, recurrence, and change. A symptom that does not settle, keeps coming back, gets worse, appears as a lump or sore, or feels unusual for your body should be checked.

For people with a cervix, cervical screening should continue even after HPV vaccination, because vaccination prevents many infections but does not treat existing infection and does not cover every cancer-causing HPV type. For people without a cervix, there is no equivalent routine HPV screening pathway for the general public, so symptom awareness and vaccination become even more important.

What to remember

  • HPV types are grouped by cancer risk: low-risk and high-risk.
  • HPV 6 and 11 cause most genital warts; HPV 16 and 18 cause most HPV-related cancers.
  • High-risk HPV infection usually has no symptoms until cell changes or cancer develop later.
  • Most people cannot recognise when HPV exposure happened.
  • HPV testing is mainly part of cervical screening, not a general test for all body sites.
  • Persistent lumps, bleeding, sores, pain, swallowing problems, or unusual symptoms should be reviewed by a clinician.

Sources used